A Trial of Inebilizumab in Participants With Autoimmune Hepatitis
A Trial of Inebilizumab in Participants With Autoimmune Hepatitis
Not yet recruiting · NCT07598825 · Registry updated 2026-08-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial of Inebilizumab in Participants With Autoimmune Hepatitis | Digestive System Diseases, Hepatitis, Chronic, autoimmune disease, autoimmune hepatitis, hepatitis, immune system disorder, liver disorder | Not yet recruiting | Phase 3 | 2026-08-14 | NCT07598825 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amgen | 180 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| American Research Corporation | San Antonio | United States | 7 |
| Amicis Research Center | Northridge | United States | 4 |
| Applied Research Center of Arkansas | Little Rock | United States | 11 |
| Beijing Friendship Hospital, Capital Medical University | Beijing | China | 64 |
| Indiana University | Indianapolis | United States | 160 |
| Inland Empire Liver Foundation | Rialto | United States | 4 |
| Methodist Cardiovascular Consultants - Dallas | Dallas | United States | 1 |
| Peking Union Medical College Hospital | Beijing | China | 201 |
| Peking University First Hospital | Beijing | China | 163 |
| Renji Hospital Shanghai Jiaotong University school of medicine | Shanghai | China | 3 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 125 |
| The Second Hospital of Anhui Medical University | Hefei | China | 25 |